טוען...
Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
BACKGROUND: Cells within breast cancer stem cell populations have been confirmed to have a CD44(+)CD24(−) phenotype. Strong expression of CD44 plays a critical role in numerous types of human cancers. CD44 is involved in cell differentiation, adhesion, and metastasis of cancer cells. METHODS: In thi...
שמור ב:
| Main Authors: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3143907/ https://ncbi.nlm.nih.gov/pubmed/21792314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S21431 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|